Journal Information
Vol. 87. Issue 1.
Pages 34-41 (1 July 2017)
Vol. 87. Issue 1.
Pages 34-41 (1 July 2017)
Original Article
Full text access
Multiple organ failure after spontaneous return of circulation in cardiac arrest in children
Fallo multiorgánico tras la recuperación de la circulación espontánea en la parada cardiaca en el niño
Tania Carbayoa,b,c, Alba de la Mataa,b,c, Marina Sáncheza,b,c, Jesús López-Hercea,b,c,
Corresponding author
, Jimena del Castilloa,b,c, Angel Carrilloa,b,c, Spanish Working Group on Paediatric and Neonatal Cardiopulmonary Resuscitation
a Servicio de Cuidados Intensivos Pediátricos, Hospital General Universitario Gregorio Marañón, Madrid, Spain
b Instituto de Investigación Sanitaria, Hospital Gregorio Marañón, Madrid, Spain
c Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain
This item has received
Article information
Full Text
Download PDF
Figures (2)
Tables (5)
Table 1. Comparison of disease severity and multiple organ failure scores in patients that died vs. survivors.
Table 2. Changes in haemodynamic, respiratory, neurologic and laboratory parameters.
Table 3. Most relevant differences between deceased patients and survivors.
Table 4. Survival analysis.
Table 5. Multivariate survival analysis.
Show moreShow less

To assess the frequency of the multiple organ failure and the prognostic value of multiple organ failure scores in children who have recovered from an in-hospital cardiac arrest.

Patients and methods

A single centre, observational, and retrospective study was conducted on children between 1 month and 16 years old who suffered an in-hospital cardiac arrest and achieved return of spontaneous circulation (ROSC). In the first 24–48h and between the fifth and the seventh day after ROSC, a record was made of the scores on paediatric severity (PRISM and PIM II) and multiple organ failure scales (PELOD and P-MODS), along with the clinical and analytical data, and including monitoring and treatment, mortality and cause of death.


Of the total of 41 children studied, 70.7% were male, and the median age was 38 months. The overall mortality during admission was 41.5%, with 14.6% dying in the first 48h, and 7.6% in the following 3–5 days. In the first 48h, clinical severity and multiple organ failure scores were higher in the patients that died than in survivors (PRISM 29 vs. 21) p=0.125, PIM II (26.8% vs. 9.2%) p=0.02, PELOD (21 vs. 12) p=0.005, and P-MODS (9 vs. 6) p=0.001. Between the fifth and seventh day, the scores on the four scales were also higher in patients who died, but only those of the PELOD (20.5 vs. 11) p=0.002 and P-MODS (6.5 vs. 3) p=0.003 reached statistical significance.


Mortality in children after return of spontaneous circulation after cardiac arrest is high. The multiple organ failure after return of spontaneous circulation after cardiac arrest in children is associated with increased mortality.

Cardiac arrest
Cardiopulmonary resuscitation
Return of spontaneous circulation
Multiple organ failure

Estudiar la incidencia del fallo multiorgánico (FMO) y el valor pronóstico de las puntuaciones de FMO en los niños que se han recuperado de una parada cardiaca (PC) intrahospitalaria.

Pacientes y métodos

Estudio unicéntrico, observacional, retrospectivo, en niños menores de 16 años, que presentaron una PC intrahospitalaria y alcanzaron la recuperación de la circulación espontánea (RCE). Se registraron las puntuaciones de las escalas de gravedad (PRISM y PIM II) y FMO (PELOD y P-MODS), la mortalidad y la causa del fallecimiento.


Se estudió a 41 niños (70,7% varones), con una mediana de edad de 38 meses. Durante el ingreso falleció el 41,5% (el 14,6% en las primeras 48h y un 7,3% en los siguientes 5 días). En las primeras 48h, las puntuaciones de gravedad clínica y de FMO fueron más altas en los fallecidos que en los supervivientes (PRISM 29 frente a 21), p=0,125, PIM II (26,8% frente a 9,2%), p=0,021, PELOD (21 frente a 12), p=0,005, y P-MODS (9 frente a 6), p=0,001. Entre el 5.° y el 7.° día las puntuaciones de las 4 escalas fueron también mayores en los fallecidos, pero solo las escalas PELOD (20,5 frente a 11), p=0,002, y P-MODS (6,5 frente a 3), p=0,003, alcanzaron significación estadística.


La mortalidad de los niños que se recuperan de una PC es elevada. El FMO tras la RCE de una PC en el niño se asocia a una mayor mortalidad.

Palabras clave:
Parada cardiaca
Reanimación cardiopulmonar
Recuperación de la circulación espontánea
Fracaso multiorgánico
Full Text

Cardiac arrest (CA) is defined as a sudden, unexpected and potentially reversible stop of spontaneous blood flow and respiration.1 The incidence of in-hospital CA in children ranges between 0.19 and 2.45 per 1000 hospital admissions.2

The goal of cardiopulmonary resuscitation (CPR) is the return of spontaneous circulation (ROSC). In adults, more than half of the patients that achieve ROSC do not survive to discharge, and the most frequent causes of death are brain death and multiple organ failure (MOF).3

Multiple organ failure is defined as failure of two or more organ systems that cannot sustain their activity spontaneously. It is the leading cause of death in intensive care units both in children and adults.4

Following CA, all organs are affected by an ischaemia–reperfusion phenomenon that increases the risk of MOF. Several studies in adults have reported that the development of acute kidney failure,5 acute adrenal insufficiency6,7 or disseminated intravascular coagulation, higher scores in disease severity scales such as APACHE II8,9 or MOF are associated with increased mortality.10 However, only one study in adults has described a high incidence of MOF after CA associated with an increased mortality that appeared to be driven by haemodynamic dysfunction and oxygenation impairment.3

There are no studies in children analysing the prevalence of MOF after CA or whether the development of MOF post CA carries a poorer prognosis.

The aim of our study was to analyse the outcomes of children that achieve ROSC after CA, determine the incidence of MOF, and assess the predictive power of the Pediatric Risk of Mortality (PRISM)11 and Pediatric Index of Mortality II (PIM II) disease severity scores, the Pediatric Multi Organ Dysfunction Score (P-MODS)12 and Pediatric Logistic Organ Dysfunction (PELOD)13 paediatric MOF scores and other monitoring and laboratory parameters that may be altered following ROSC,14–24 as well as the causes of death.25

Patients and methods

We conducted a single-centre observational retrospective study in which we included children that experienced in-hospital CA and achieved ROSC between December 2007 and June 2013.

The inclusion criteria were: age 1 month to 16 years, in-hospital CA with ROSC after CPR. We excluded children that had out-of-hospital CA and children that did not achieve ROSC after CPR.

We collected data for the following variables: age, sex, weight, history of preterm birth, heart, respiratory, neurologic, gastrointestinal, or renal disease, cancer, blood disorder, congenital anomalies or surgery. We documented the past history of CA, whether the patient had required treatment with angiotensin-converting enzyme (ACE) inhibitors in the past, the history of organ failure prior to CA, the cause and type of CA (cardiac or respiratory), ECG rhythm, setting of diagnosis (paediatric ICU, inpatient ward, operating room, emergency room or other), time elapsed between arrest and initiation of CPR, and duration of CPR.

The following data were collected in the first 24–48h and between day five and seven post CA: predominant ECG rhythm, echocardiography (if performed), blood pressure (BP), heart rate (HR), breathing rate, body temperature, diuresis, administration and dosage of inotropes, sedatives, insulin and antibiotics, type of nutrition, mechanical ventilation, peak flow rate, FiO2 and end expiratory pressure; continuous renal replacement therapy (CRRT), ventricular assist devices and extracorporeal membrane oxygenation (ECMO), presence of infection and its location, haemorrhage and/or pneumothorax.

We also collected data for the following laboratory variables: arterial and/or venous blood gases (PO2, PCO2, O2 saturation, pH, bicarbonate and base excess), chemistry panel (glucose, ions, transaminases, total bilirubin, bicarbonate, lactate, creatinine, urea, C-reactive protein, procalcitonin, BNP, troponin, CPK-MB, cortisol) blood counts (haemoglobin, white blood cells, platelets) and coagulation tests (INR, aPTT, fibrinogen, D dimer). To assess neurologic outcomes, we collected data for seizures, evaluation of pupillary response, continuous EEG monitoring, bispectral index (BIS), cerebral oxygen monitoring, findings of computed tomography or magnetic resonance imaging, and use of therapeutic hypothermia including time elapsed between CA and initiation of hypothermia and its duration. For patients that died, we collected the cause of death and the days elapsed between CA and death.

We calculated the prognostic scores at 24–48h and at day five to seven after ROSC, using the PRISM,11 PELOD,13 P-MODS12 and PIM II paediatric scales.

We conducted the statistical analysis with the software SPSS, version 21. We have expressed the data using the median and interquartile range (IQR) as they did not follow a normal distribution. We analysed the association between PRISM, PELOD, P-MODS and PIM II scores and mortality by comparing the number of deceased and surviving patients with the nonparametric Mann–Whitney U test. Statistical significance was defined as a p-value of less than 0.05. We analysed survival by means of Kaplan–Meier curves. We performed multivariate survival analysis by means of Cox regression, excluding the confounding variables of the selected reduced model.


We analysed data for 41 patients with a median age of 38 months (IQR, 5.5–94 months) and a median weight of 12kg (IQR, 5–22kg). Seventy percent were male.

Past history

Ninety percent of the children had a past history of disease (heart disease in 75%, preterm birth in 15%, respiratory disease in 7.5%, neurologic in 5%, gastrointestinal in 10%, renal in 5%, and cancer in 2.5%; 17.1% had congenital anomalies, 10% had a history of recurrent infection, 46.3% had multiple prior surgeries and 9.6% presented with malnutrition). We found a prior history of CA in 17.5% of patients, and 27.5% were being treated with ACE inhibitors. Of all patients, 47.5% had a history of MOF that predated CA.

Characteristics of cardiac arrest and cardiopulmonary resuscitation

The aetiology of CA was cardiovascular in 62.5% of patients, respiratory in 27.5%, infectious in 5%, neurologic in 2.5% and other in the remaining 2.5%. In 74.4%, the arrest originated in the heart and in 25.6% in the respiratory system.

The setting where CA took place was the paediatric ICU in 69.2% of cases, the operating room in 12.8%, the emergency department in 2.6% and elsewhere in the hospital in 15.4%.

In 97.4% of the patients, CPR was initiated within 1min of CA, and in 2.6% between 4 and 10min post CA.

The cardiac rhythm at the time of CA was asystole or severe bradycardia in 65% of patients, pulseless electrical activity in 22.5% and ventricular fibrillation or pulseless ventricular tachycardia in 12.5%. In 69.7% of patients, the duration of the arrest was less than 10min, with a median duration of four minutes (IQR, 1.5–15min).

Patient outcomes after return of spontaneous circulation

Seventeen children (41.5%) died during their stay. The time elapsed between ROSC and death was 9.5 days (IQR, 2–19.7 days).

Outcomes in the first 24–48h

Fig. 1 summarises patient outcomes.

Fig. 1.

Patient outcomes.


In the first 24–48h after ROSC, 12 patients (29.3%) had another CA. Six patients (14.6%) died in the first 24–48h following ROSC (two due to a new CA without ROSC, two due to brain death, one due to MOF and one following withdrawal of life-sustaining treatment).

The PIM II, PELOD and P-MODS scores of children that died were significantly higher than those of survivors. The PRISM score was also higher in children that died compared to survivors, but the difference was not statistically significant (Table 1).

Table 1.

Comparison of disease severity and multiple organ failure scores in patients that died vs. survivors.

Median  IQR  Median  IQR  Median  IQR 
PRISM  22  16–31  29  16.5–35.5  21  15–27  0.125 
PIM II  14.9  5.3–36.4  26.8  14.9–44.3  9.2  4.6–28.3  0.021 
PELOD  20  12–22  21  16.5–30.5  12  11–21  0.005 
P–MODS  5–9  7.5–10  4–7  0.001 
5–7 days
Median  IQR  Median  IQR  Median  IQR 
PRISM  14  8.5–18.5  17  13.5–20.2  11  8–18  0.114 
PIM II  6.9  2.7–19.4  14  4.8–31.6  6.5  2.1–16.9  0.103 
PELOD  11  11–20  20.5  13.2–21.7  11  10–11  0.002 
P–MODS  3–6  6.5  4.5–10  2–4.2  0.003 

Of all patients, 97.6% were treated with sedation, inotropic therapy and mechanical ventilation. Bilaterally dilated pupils were observed in 5.4% of patients, and moderate to small pupillary reactions in 16.2%. Seizures were documented in 4.9% of patients.

The inotropic score was higher in patients that died (median, 50) compared to survivors (median, 41), although the difference was not statistically significant (p=0.2). We also found no differences in lactate clearance (0.85 in survivors vs. 0.75 in deceased patients; p=0.11).

Outcomes at five to seven days

Between days five and seven after ROSC, three patients (7.3%) had a new CA, and all recovered.

Three patients (7.3% of the total) died between days five and seven (one due to MOF, one due to brain death, and one following withdrawal of life-sustaining treatment). Eight patients died after day seven (four due to MOF, 2 due to a new CA from which they did not recover, one from a brain haemorrhage and one due to pulmonary haemorrhage).

The PELOD and P-MODS scores of the children that died were significantly higher compared to those of survivors. The PRISM and PIM II scores were also higher in deceased patients, but the difference was not statistically significant (Table 1).

The inotropic score at five to seven days of patients that died was significantly higher (43.5; IQR, 40–65) compared to survivors (25; IQR, 18.2–30.2) (p=0.001). There was no difference in lactate clearance between survivors (0.36) and deceased patients (0.28) (p=0.122).

Pupillary reactions were moderate to small in 3.7% of patients, and normal in all others. At this time, 89.3% of patients required sedation, 92.9% inotropic therapy and 75% mechanical ventilation.

Comparison of variables over time

Table 1 summarises the scores in the PRISM and PIM II paediatric disease severity scales as well as the MOF PELOD and P-MODS. The scores in all scales fell between the two time points of 24–48h and days five to seven (PRISM, p<0.001; PIM II, p=0.011; PELOD, p=0.004; P-MODS, p=0.001).

Table 2 presents the median and IQR of the main variables under study at 24–48h and days five to seven from ROSC.

Table 2.

Changes in haemodynamic, respiratory, neurologic and laboratory parameters.

Variable24–48h5–7 daysp
Median  IQR  Median  IQR 
SBP (mmHg)  67  56.5–74  71  66–74  0.299 
DBP (mmHg)  42  38–45  41  38.5–48.5  0.500 
MAP (mmHg)  49.7  44.2–54.3  53.3  48.5–56.8  0.872 
Heart rate (bpm)  152  137–169  145  125–155  <0.001 
Dopamine dose (μg/kg/min)  10  5–10  5–10  0.016 
Adrenaline dose (μg/kg/min)  0.2  0.1–0.4  0.14  0.08–0.25  0.005 
Breathing rate (bpm)  33  22–41  32  25–45  0.979 
Peak flow rate (cmH2O)  27.5  24–35  27  22–32.5  0.170 
PaO2 (mmHg)  50  41–68  58  39–67  0.179 
FiO2  70  50–100  50  40–82.5  0.036 
PaO2/FiO2  69  48.5–108.3  104  62.2–134  0.942 
PaCO2 (mmHg)  49  43.2–62.7  48  44–59  0.387 
Arterial O2 saturation (%)  90.9  79.6–93.1  88.4  75.6–94.9  0.360 
PvO2 (mmHg)  24  11.7–33.3  25.5  18.5–32.5 
PvCO2 (mmHg)  62.5  52.7–87  58.5  51–63.7 
Venous O2 saturation (%)  45.9  21.2–62.4  48.8  38.1–72.8 
Bispectral index  28  23–38  31  21.5–34  0.889 
Cerebral O2 saturation (%)  40  33–81.5  47.5  27.8–83  0.655 
Predominant temperature (°C)  36  34.5–36  36.5  36–37  0.320 
Minimum temperature (°C)  34.5  34– 35.3  36  35.3–36  0.004 
Duration of hypothermia (h)  32  21–47     
Maximum temperature (°C)  37  36–38  37.4  36.8–37.9  0.346 
pH  7.22  7.1–7.3  7.37  7.3–7.4  <0.001 
Minimum HCO3  20.1  15.5–22.7  26.9  24.3–28.7  0.002 
Maximum HCO3  30.6  26–33.7  33  29.1–34.1  0.606 
Base excess  −8.4  (−14.3)–(−1.2)  3.3  1.6–8.2  0.068 
Maximum lactate  7.9  3.1–13.6  1.5  1.2–2.2  <0.001 
Minimum lactate  0.7–2.3  0.9  0.8–1.1  0.417 
Maximum glucose  256  174.7–322.2  148.5  123–162.2  <0.001 
Minimum glucose  97  75–128  101.5  86.7–112  0.925 

DBP, diastolic arterial blood pressure; FiO2, fraction of inspired oxygen; IQR, interquartile range; MAP, mean arterial pressure; PaCO2, arterial partial carbon dioxide pressure; PaO2, arterial partial oxygen pressure; PvCO2, venous partial carbon dioxide pressure; PvO2, venous partial oxygen pressure; SBP, arterial systolic blood pressure.

We found no significant differences in the haemodynamic parameters (BP and HR) or the dosage of inotropic agents between the two time points. The FiO2 was higher in the first 48h compared to days five to seven (p=0.036). There were no statistically significant differences in any of the remaining respiratory parameters. Therapeutic hypothermia was used in 19 patients in the first 48h. There were no significant differences in BIS and cerebral oxygen saturation values between the two periods. At the day five-to-seven time point, fibrinogen levels had increased (p=0.025) while the INR had decreased (p=0.037). Urine volume was greater in the first 48h (p=0.005). As for liver function parameters, AST levels were higher (p=0.035) and GGT levels lower (p=0.001) in the first 48h. Electrolyte levels, blood gases, pH (p=0.001) and bicarbonate levels (p=0.002) were lower in the 48h, while lactate and glucose levels were higher (p<0.001 for both).

Survival analysis

The Kaplan–Meier survival analysis found a survival of 82.9% of the patients in the seven days following CA. The mean survival was 207 days (CI, 154–260). Fig. 2 shows the survival curve.

Fig. 2.

Survival curve.


Table 3 summarises the main differences in the variables under study between deceased patients and survivors. In children that died, systolic BP and PaO2 at 24h were significantly lower, while the need for ECMO and CRRT were higher.

Table 3.

Most relevant differences between deceased patients and survivors.

  N  Survivors  Deceased  p 
Age (months)  40  Median (IQR)
31.0 (6.0–95.0) 
Median (IQR)
44.0 (4.0–91.5) 
Setting of CA
PICU  26  65.4%  34.6%  0.263 
ED/ward  0%  100%   
Other  13  45.5%  54.5%   
Aetiology of CA
Respiratory  11  63.6%  36.4%   
Cardiac  24  50.0%  50.0%  0.697 
Infectious  50.0%  50.0%   
Neurologic  100%  0%   
Other  100%  0%   
Type of CA
Respiratory  10  50%  50%  0.556 
Cardiac  28  60.7%  39.3%   
Duration of CA
≤ 10min  23  69.6%  34.6%  0.110 
> 10min  10  40.0%  60.0%   
Asystole-bradycardia  26  53.8%  46.2%  0.793 
PVTC or VF  60.0%  40.0%   
Other  66.7%  33.3%   
SBP (mmHg) 24h from ROSC  39  Median (IQR)
69 (62–81) 
Median (IQR)
57 (50.5–71.0) 
MAP (mmHg) 24h from ROSC  39  Median (IQR)
52.4 (45.2–57.1) 
Median (IQR)
45.0 (42.2–52.5) 
HR (bpm) 24h from ROSC  40  Median (IQR)
162 (140–170) 
Median (IQR)
145 (132–161) 
PaO2(mmHg) 24h from ROSC  39  Median (IQR)
60.0 (43.5–79.0) 
Median (IQR)
45.0 (37.0–49.0) 
PaCO2(mmHg) 24h from ROSC  39  Median (IQR)
47.0 (41.8–51.8) 
Median (IQR)
62.0 (45.5–66.0) 
Yes  12  25.0%  75.0%  0.006 
No  28  71.4%  28.6%   
Yes  15  26.7%  73.3%  0.002 
No  25  76.0%  24.0%   

CA, cardiac arrest; CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation; ED, emergency department; HR, heart rate; IQR, interquartile range; MAP, mean arterial pressure; PICU, paediatric intensive care unit; PVTC, pulseless ventricular tachycardia; ROSC, return of spontaneous circulation; SBP, systolic blood pressure; VF, ventricular fibrillation.

Table 4 shows the association of disease severity and MOF risk scales with survival. The P-MODS was the scale with the strongest correlation with survival. In the first 24h, each one-point increase in this score was associated with a 30.9% increase in mortality risk (p=0.001) compared to an increase of 2% per point in the PELOD (p=0.019) or the PRISM (p=0.021). The analysis of the PIM II scores did not find statistically significant differences.

Table 4.

Survival analysis.

  Exp(BCI  p 
P-MODS (24h)  1.310  1.111–1.545  0.001 
P–MODS (5–7 days)  1.409  1.141–1.740  0.001 
PELOD (24h)  1.017  1.003–1.031  0.019 
PELOD (5–7 days)  1.023  1.002–1.044  0.029 
PRISMS (24h)  1.019  1.003–1.035  0.021 
PRISMS (5–7 days)  1.055  0.985–1.130  0.129 
PIM II (24h)  1.031  0.999–1.063  0.056 
PIM II (5–7 days)  1.048  0.987–1.112  0.124 

CI, confidence interval.

Between days five and seven, mortality risk increased by 40.9% with each one-point increase in the P-MODS score (p=0.001) compared to 2.3% for the PELOD scale (p=0.029), while the association was not statistically significant for the PRISM and PIM II scores.

Table 5 presents the results of the multivariate analysis for both time periods.

Table 5.

Multivariate survival analysis.

  Exp(BCI  p 
P-MODS (24h)  1.310  1.094–1.568  0.003 
Peak inspiratory flow rate (24h) (mmHg)  1.075  1.003–1.153  0.040 
Systolic blood pressure (24h) (mmHg)  0.956  0.905–1.009  0.103 
P-MODS (5–7 days)  2.342  1.196–4.589  0.013 
Peak inspiratory flow rate (5–7 days) (mmHg)  1.142  0.974–1.339  0.101 
Inotropic score (5–7 days)  0.963  0.927–1.000  0.053 

CI, confidence interval.

In the first 24h, the only variable associated with survival was the ventilator peak inspiratory flow rate, with the risk of mortality increasing by 7.5% with each unit increase in pressure (CI, 1.003–1.153; p=0.04). We did not find a statistically significant association for any of the variables analysed for days five to seven.


In-hospital cardiopulmonary arrest in the paediatric age group carries a high mortality. The percentage of children that survive CA is highly variable.1,26–30 A considerable proportion do not recover from CA, while other children achieve ROSC but die within a few days or weeks.

The survival of children that achieved ROSC after CA in our study was 58.5%, a proportion that was similar to those reported in other recent studies in the paediatric pouplation.26–30

This is the first study to analyse the prognostic power of MOF after ROSC in paediatric CA. Multiple organ failure was the main cause of death in 35.3% of the patients in our study. The scores in the PELOD and P-MODS MOF scales at 24–48h and five to seven days were significantly associated with mortality, which confirms the relevance of MOF in predicting the outcomes of children that achieve ROSC after CA.

The scores on the four scales were higher at 24–48h from admission compared to five to seven days. This probably reflects the greater initial severity after ROSC following CA. But we also need to take into account that some of the most severely ill patients, who logically would have higher scores early after ROSC, died in the first few days and were not assessed between days five and seven.

A study conducted in adults found that 66% of patients that had ROSC after in-hospital CA developed MOF, and that the most common organ failures, which also carry the worst prognosis, were cardiovascular and respiratory.3

In our study, ventilator peak inspiratory flow rates at 24–48h from CA were higher in patients that died. However, we did not identify any factors associated with increased mortality at five to seven days.

Limitations of the study

There are limitations to our study. It is a single-centre retrospective study with a relatively small sample size, and thus prospective multicentric studies are required to confirm its findings. In addition, our study only assessed patients at two times: in the first 24–48h and five to seven days post CA. However, of all patients that died, the largest percentage corresponded to those that died after seven days, of who 50% died due to MOF. Therefore, future studies should evaluate patients after seven days post CA to better assess the clinical course of these patients.


The mortality of children that recover from CA is high. The development of MOF following recovery from in-hospital CA in children is associated with increased mortality.

Further research is required to identify the organ systems that are most likely to be injured following ROSC to develop new therapeutic approaches aimed at reducing multiple organ injury and improving patient prognosis.

Conflict of interests

The authors have no conflict of interests to declare.

A. Carrillo, J. López-Herce.
Definitions and prevention of cardiorespiratory arrest in children.
An Pediatr (Barc), 65 (2006), pp. 140-146
K.T. Van Voorhis, T.S. Willis.
Implementing a pediatric rapid response system to improve quality and patient safety.
Pediatr Clin North Am, 56 (2009), pp. 919-933
B.W. Roberts, J.H. Kilgannon, M.E. Chansky, N. Mittal, J. Wooden, J.E. Parrillo, et al.
Multiple organ dysfunction after return of spontaneous circulation in postcardiac arrest syndrome.
Crit Care Med, 41 (2013), pp. 1492-1501
J. Forero Gómez.
Síndrome de disfunción orgánica múltiple en pediatría.
MedUNAB, 7 (2004), pp. 21-28
J. Yanta, F.X. Guyette, A.A. Doshi, C.W. Callaway, J.C. Rittenberger.
Post cardiac arrest service. Renal dysfunction is common following resuscitation from out-of-hospital cardiac arrest.
Resuscitation, 84 (2013), pp. 1371-1374
C. Adrie, I. Laurent, M. Monchi, A. Cariou, J.F. Dhainaou, C. Spaulding.
Postresuscitation disease after cardiac arrest: a sepsis-like syndrome.
Curr Opin Crit Care, 10 (2004), pp. 208-212
J.B. Miller, M.W. Donnino, M. Rogan, N. Goyal.
Relative adrenal insufficiency in post-cardiac arrest shock is under-recognized.
Resuscitation, 76 (2008), pp. 221-225
T. Wada, S. Jesmin, S. Gando, Y. Yanagida, A. Mizugaki, S.N. Sultana, et al.
Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome.
Crit Care, 16 (2012), pp. R171
C. Adrie, M. Monchi, I. Laurent, S. Um, S.B. Yan, M. Thuong, et al.
Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.
J Am Coll Cardiol, 46 (2005), pp. 21-28
J.C. Rittenberger, S.A. Tisherman, M.B. Holm, F.X. Guyette, C.W. Callaway.
An early, novel illness severity score to predict outcome after cardiac arrest.
Resuscitation, 82 (2011), pp. 1399-1404
S. Prieto Espuñes, J. López-Herce Cid, C. Rey Galán, A. Medina Villanueva, A. Concha Torre, P. Martínez Camblor.
Índices pronósticos de mortalidad en cuidados intensivos pediátricos.
An Pediatr (Barc), 66 (2007), pp. 345-350
A.L. Graciano, J.A. Balko, D.S. Rahn, N. Ahmad, B.P. Giroir.
The Pediatric Multiple Organ Dysfunction Score (P-MODS): development and validation of an objective scale to measure the severity of multiple organ dysfunction in critically ill children.
Crit Care Med, 33 (2005), pp. 1484-1491
S. Leteurtre, A. Martinot, A. Duhamel, F. Proulx, B. Grandbastien, J. Cotting, et al.
Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study.
J.H. Kilgannon, B.W. Roberts, L.R. Reihl, M.E. Chansky, A.E. Jones, R.P. Dellinger, et al.
Early arterial hypotension is common in the post-cardiac arrest syndrome and associated with increased in-hospital mortality.
Resuscitation, 79 (2008), pp. 410-416
S. Trzeciak, A.E. Jones, J.H. Kilgannon, B. Milcarek, K. Hunter, N.I. Shapiro, et al.
Significance of arterial hypotension after resuscitation from cardiac arrest.
Crit Care Med, 37 (2009), pp. 2895-2903
K. Gebhardt, F.X. Guyette, A.A. Doshi, C.W. Callaway, J.C. Rittenberger.
Post cardiac arrest service. Prevalence and effect of fever on outcome following resuscitation from cardiac arrest.
B.W. Roberts, J.H. Kilgannon, M.E. Chansky, N. Mittal, J. Wooden, S. Trzeciak.
Association between postresuscitation partial pressure of arterial carbon dioxide and neurological outcome in patients with post-cardiac arrest syndrome.
Circulation, 127 (2013), pp. 2107-2113
D.G. Beiser, G.E. Carr, D.P. Edelson, M.A. Peberdy, T.L. Hoek.
Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation.
Resuscitation, 80 (2009), pp. 624-630
A. Geppert, G. Zorn, G. Delle-Karth, M. Koreny, P. Siostrzonek, G. Heinz, et al.
Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation.
Crit Care Med, 31 (2003), pp. 805-811
H.R. Chua, N. Glassford, R. Bellomo.
Acute kidney injury after cardiac arrest.
Resuscitation, 83 (2012), pp. 721-727
J.C. Reynolds, B.J. Lawner.
Management of the post-cardiac arrest syndrome.
J Emerg Med, 42 (2012), pp. 440-449
T. Wada, S. Gando, A. Mizugaki, Y. Yanagida, S. Jesmin, H. Yokota, et al.
Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest síndrome—fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Thromb Res, 132 (2013), pp. 64-69
M.A. Peberdy, C.W. Callaway, R.W. Neumar, R.G. Geocadin, J.L. Zimmerman, M. Donnino, et al.
Part 9: Post-Cardiac Arrest Care 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Circulation, 122 (2010), pp. S768-S786
M.D. Manole, P.M. Kochanek, E.L. Fink, R.S. Clark.
Post-cardiac arrest syndrome: focus on the brain.
Curr Opin Pediatr, 21 (2009), pp. 745-750
S. Laver, C. Farrow, D. Turner, J. Nolan.
Mode of death after admission to an intensive care unit following cardiac arrest.
Intensive Care Med, 30 (2004), pp. 2126-2128
J. López-Herce, J. del Castillo, M. Matamoros, S. Cañadas, A. Rodríguez-Calvo, C. Cecchetti, et al.
Factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.
Intensive Care Med, 39 (2013), pp. 309-318
J. López-Herce, J. del Castillo, M. Matamoros, S. Canadas, A. Rodriguez-Calvo, C. Cecchetti, et al.
Post return of spontaneous circulation factors associated with mortality in pediatric in-hospital cardiac arrest: a prospective multicenter multinational observational study.
P.A. Meaney, V.M. Nadkarni, E.F. Cook, M. Testa, M. Helfaer, W. Kaye, et al.
Higher survival rates among younger patients after pediatric intensive care unit cardiac arrest.
Pediatrics, 118 (2006), pp. 2424-2433
K.L. Meert, A. Donaldson, V. Nadkarni, K.S. Tieves, C.L. Schleien, R.J. Brilli, et al.
Multicenter cohort study of in-hospital pediatric cardiac arrest.
Pediatr Crit Care Med, 10 (2009), pp. 544-553
R.J. Berens, L.D. Cassidy, J. Matchey, D. Campbell, K.D. Colpaert, T. Welch, et al.
Probability of survival based on etiology of cardiopulmonary arrest in pediatric patients.
Paediatr Anaesth, 21 (2011), pp. 834-840

Red de Salud Maternoinfantil y del Desarrollo (Mother and Child Health and Development Network, RedSAMID). RETICS funded by the 2008–2011 National Plan for R&D&I of Spain, Instituto de Salud Carlos III—General Subdirectorate of Research Evaluation and Promotion, European Regional Development Fund (ERDF), reference RD12/0026.

Please cite this article as: Carbayo T, de la Mata A, Sánchez M, López-Herce J, del Castillo J, Carrillo A, et al. Fallo multiorgánico tras la recuperación de la circulación espontánea en la parada cardiaca en el niño. An Pediatr (Barc). 2017;87:34–41.

Copyright © 2016. Asociación Española de Pediatría
Anales de Pediatría (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?